Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Atomoxetine, Diurnal Profiles of Cortisol and α-amylase, Possible Biological Markers of Treatment Success

NCT03075579 is registered in ClinicalTrials.gov with Praxis für kleine und grosse Leute as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03075579 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Atomoxetine, Diurnal Profiles of Cortisol and α-amylase, Possible Biological Markers of Treatment Success
Lead sponsor
Praxis für kleine und grosse Leute
Phase
Observational
Overall status
Unknown status
Start date
December 1, 2016
Completion date
July 31, 2018
Enrollment
50 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

adhd